Tumor suppressive microRNA-218 inhibits cancer cell migration and invasion by targeting focal adhesion pathways in cervical squamous cell carcinoma

International Journal of Oncology

Volumn 42, Issue 5, 2013, Pages 1523-1532

  Yamamoto, Noriko ^a   Kinoshita, Takashi ^a   Nohata, Nijiro ^a   Itesako, Toshihiko ^b   Yoshino, Hirofumi ^b   Enokida, Hideki ^b   Nakagawa, Masayuki ^b   Shozu, Makio ^a   Seki, Naohiko ^a  

^a CHIBA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b KAGOSHIMA UNIVERSITY   (Japan)

Author keywords

Cervical cancer; Focal adhesion; LAMB3; MicroRNA; MiR 218; Tumor suppressor

Indexed keywords

BETA ACTIN; GLYCOGEN SYNTHASE KINASE 3BETA; LAMININ; LAMININ B3; MICRORNA; MICRORNA 218; MITOGEN ACTIVATED PROTEIN KINASE 9; P21 ACTIVATED KINASE 1; PHOSPHOINOSITIDE DEPENDENT PROTEIN KINASE 1; RHOA GUANINE NUCLEOTIDE BINDING PROTEIN; SOMATOMEDIN C RECEPTOR; TUMOR SUPPRESSOR PROTEIN; UNCLASSIFIED DRUG; VASCULOTROPIN RECEPTOR 1;

ADULT; AGED; ARTICLE; CANCER INVASION; CELL ADHESION; CELL DIFFERENTIATION; CELL MIGRATION; CELL PROLIFERATION; CELL SURVIVAL; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FOCAL ADHESION; GENE EXPRESSION; HELA CELL; HUMAN; HUMAN CELL; METASTASIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; UTERINE CERVIX CARCINOMA;

CARCINOMA, SQUAMOUS CELL; CELL ADHESION MOLECULES; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; FEMALE; FOCAL ADHESIONS; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MICRORNAS; NEOPLASM INVASIVENESS; SIGNAL TRANSDUCTION; UTERINE CERVICAL NEOPLASMS;

EID: 84875976552     PISSN: 10196439     EISSN: 17912423     Source Type: Journal    
DOI: 10.3892/ijo.2013.1851     Document Type: Article

References (40)

1. Jemal A, Bray F, Center MM, Ferlay J, Ward E and Forman D: Global cancer statistics. CA Cancer J Clin 61: 69-90, 2011.
2. Walboomers JM, Jacobs MV, Manos MM, et al: Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol 189: 12-19, 1999. (Pubitemid 29406813)
3. Muñoz N, Bosch FX, De Sanjosé S, et al: Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Engl J Med 348: 518-527, 2003. (Pubitemid 36159887)
4. Clifford GM, Smith JS, Plummer M, Muñoz N and Franceschi S: Human papillomavirus types in invasive cervical cancer worldwide: a meta-analysis. Br J Cancer 88: 63-73, 2003.
5. Band V, Dalal S, Delmolino L and Androphy EJ: Enhanced degradation of p53 protein in HPV-6 and BPV-1 E6-immortalized human mammary epithelial cells. EMBO J 12: 1847-1852, 1993. (Pubitemid 23157700)
6. Lechnerl MS, Mackl DH, Finicle AB, Crook T, Vousden KH and Laiminsl LA: Human papillomavirus E6 proteins bind p53 in vivo and abrogate p53-mediated repression of transcription. EMBO J 11: 3045-3052, 1992.
7. Thomas M, Pim D and Banks L: The role of the E6-p53 interaction in the molecular pathogenesis of HPV. Oncogene 18: 7690-7700, 1999. (Pubitemid 30052696)
8. Münger K and Howley PM: Human papillomavirus immortalization and transformation functions. Virus Res 89: 213-228, 2002. (Pubitemid 35351540)
9. Filipowicz W, Bhattacharyya SN and Sonenberg N: Mechanisms of post-transcriptional regulation by microRNAs: are the answers in sight? Nat Rev Genet 9: 102-114, 2008.
10. Nelson KM and WEiss GJ: MicroRNAs and cancer: past, present, and potential future. Mol Cancer Ther 7: 3655-3660, 2008.
11. Esquela-Kerscher A and Slack FJ: Oncomirs - microRNAs with a role in cancer. Nat Rev Cancer 6: 259-269, 2006.
12. Kikkawa N, Hanazawa T, Fujimura L, et al: miR-489 is a tumour-suppressive miRNA target PTPN11 in hypopharyngeal squamous cell carcinoma (HSCC). Br J Cancer 103: 877-884, 2010.
13. Nohata N, Hanazawa T, Kikkawa N, et al: Tumour suppressive microRNA-874 regulates novel cancer networks in maxillary sinus squamous cell carcinoma. Br J Cancer 105: 833-841, 2011.
14. Kano M, Seki N, Kikkawa N, et al: miR-145, miR-133a and miR-133b: tumor-suppressive miRNAs target FSCN1 in esophageal squamous cell carcinoma. Int J Cancer 127: 2804-2814, 2010.
15. Moriya Y, Nohata N, Kinoshita T, et al: Tumor suppressive microRNA-133a regulates novel molecular networks in lung squamous cell carcinoma. J Hum Genet 57: 38-45, 2012.
16. Hidaka H, Seki N, Yoshino H, Yamasaki T, et al: Tumor suppressive microRNA-1285 regulates novel molecular targets: aberrant expression and functional significance in renal cell carcinoma. Oncotarget 3: 44-57, 2012.
17. Ichimi T, Enokida H, Okuno Y, et al: Identification of novel microRNA targets based on microRNA signatures in bladder cancer. Int J Cancer 125: 345-352, 2009.
18. Yoshino H, Chiyomaru T, Enokida H, et al: The tumour-suppressive function of miR-1 and miR-133a targeting TAGLN2 in bladder cancer. Br J Cancer 104: 808-818, 2011.
19. Kinoshita T, Hanazawa T, Nohata N, et al: Tumor suppressive microRNA-218 inhibits cancer cell migration and invasion through targeting laminin-332 in head and neck squamous cell carcinoma. Oncotarget 3: 1386-1400, 2012.
20. Alajez NM, Lenarduzzi M, Ito E, et al: MiR-218 suppresses nasopharyngeal cancer progression through downregulation of survivin and the SLIT2-ROBO1 pathway. Cancer Res 71: 2381-2391, 2011.
21. Uesugi A, Kozaki K-I, Tsuruta T, et al: The tumor suppressive microRNA miR-218 targets the mTOR component Rictor and inhibits AKT phosphorylation in oral cancer. Cancer Res 71: 5765-5678, 2011.
22. Tie J, Pan Y, Zhao L, et al: MiR-218 inhibits invasion and metastasis of gastric cancer by targeting the Robo1 receptor. PLoS Genet 6: e1000879, 2010.
23. Tatarano S, Chiyomaru T, Kawakami K, et al: miR-218 on the genomic loss region of chromosome 4p15.31 functions as a tumor suppressor in bladder cancer. Int J Oncol 39: 13-21, 2011.
24. Martinez I, Gardiner AS, Board KF, Monzon FA, Edwards RP and Khan SA: Human papillomavirus type 16 reduces the expression of microRNA-218 in cervical carcinoma cells. Oncogene 27: 2575-2582, 2008. (Pubitemid 351550884)
25. Gravitt PE, Peyton CL, Alessi TQ, et al: Improved amplification of genital human papillomaviruses. J Clin Microbiol 38: 357-361, 2000. (Pubitemid 30043317)
26. Mattick JS: RNA regulation: a new genetics? Nat Rev Genet 5: 316-323, 2004. (Pubitemid 38435628)
27. Lee J-W, Choi CH, Choi J-J, et al: Altered MicroRNA expression in cervical carcinomas. Clin Cancer Res 14: 2535-2542, 2008.
28. Wang X, Tang S, Le S-Y, et al: Aberrant expression of oncogenic and tumor-suppressive microRNAs in cervical cancer is required for cancer cell growth. PLoS One 3: e2557, 2008.
29. Pereira PM, Marques JP, Soares AR, Carreto L and Santos MAS: MicroRNA expression variability in human cervical tissues. PLoS One 5: e11780, 2010.
30. Li Y, Wang F, Xu J, et al: Progressive miRNA expression profiles in cervical carcinogenesis and identification of HPV-related target genes for miR-29. J Pathol 224: 484-495, 2011.
31. Rao Q, Zhou H, Peng Y, Li J and Lin Z: Aberrant microRNA expression in human cervical carcinomas. Med Oncol 29: 1242-1248, 2012.
32. Li Y, Liu J, Yuan C, Cui B, Zou X and Qiao Y: High-risk human papillomavirus reduces the expression of microRNA-218 in women with cervical intraepithelial neoplasia. J Int Med Res 38: 1730-1736, 2010.
33. Chiyomaru T, Enokida H, Kawakami K, et al: Functional role of LASP1 in cell viability and its regulation by microRNAs in bladder cancer. Urologic Oncol 30: 434-443, 2012.
34. Bartel DP, Lee R and Feinbaum R: MicroRNAs: Genomics, biogenesis, mechanism, and function. Cell 116: 281-297, 2004.
35. Guess CM and Quaranta V: Defining the role of laminin-332 in carcinoma. Matrix Biol 28: 445-455, 2009.
36. Marinkovich MP: Laminin 332 in squamous-cell carcinoma. Nat Rev Cancer 7: 370-380, 2007.
37. Carter WG, Ryan MC and Gahr PJ: Epiligrin, a new cell adhesion ligand for integrinα3β1 in epithelial basement membranes. Cell 65: 599-610, 1991.
38. Schenk S, Hintermann E, Bilban M, et al: Binding to EGF receptor of a laminin-5 EGF-like fragment liberated during MMP-dependent mammary gland involution. J Cell Biol 161: 197-209, 2003. (Pubitemid 36459091)
39. Okamoto O, Bachy S, Odenthal U, et al: Normal human keratinocytes bind to the alpha3LG4/5 domain of unprocessed laminin-5 through the receptor syndecan-1. J Biol Chem 278: 44168-44177, 2003. (Pubitemid 37377160)
40. Mizejewski GJ: Role of integrins in cancer: survey of expression patterns. Proc Soc Exp Biol Med 222: 124-138, 1999.